{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:09:40Z","timestamp":1793210980159,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:00:00Z","timestamp":1411430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10875-014-0099-z","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T03:00:34Z","timestamp":1411354834000},"page":"971-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Altered Serum Cytokine Signature in Common Variable Immunodeficiency"],"prefix":"10.1007","volume":"34","author":[{"given":"Zdenek","family":"Hel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P. H.","family":"Huijbregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Nechvatalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Vlkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Litzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","volume":"145","author":"H Chapel","year":"2009","unstructured":"Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145:709\u201327.","journal-title":"Br J Haematol"},{"key":"99_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10875-009-9357-x","volume":"30","author":"L Yel","year":"2010","unstructured":"Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30:10\u20136.","journal-title":"J Clin Immunol"},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2277-9175.124627","volume":"3","author":"R Yazdani","year":"2014","unstructured":"Yazdani R, Hakemi MG, Sherkat R, Homayouni V, Farahani R. Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Adv Biomed Res. 2014;3:2.","journal-title":"Adv Biomed Res"},{"key":"99_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","volume":"120","author":"L Hammarstr\u00f6m","year":"2000","unstructured":"Hammarstr\u00f6m L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120:225\u201331.","journal-title":"Clin Exp Immunol"},{"key":"99_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","volume":"170","author":"J Litzman","year":"2012","unstructured":"Litzman J, Nechvatalova J, Xu J, Ticha O, Vlkova M, Hel Z. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin Exp Immunol. 2012;170:321\u201332.","journal-title":"Clin Exp Immunol"},{"key":"99_CR6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2249.2002.01893.x","volume":"129","author":"V Guazzi","year":"2002","unstructured":"Guazzi V, Aiuti F, Mezzaroma I, Mazzetta F, Andolfi G, Mortellaro A, et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol. 2002;129:346\u201353.","journal-title":"Clin Exp Immunol"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2249.2006.02999.x","volume":"143","author":"M Vlkov\u00e1","year":"2006","unstructured":"Vlkov\u00e1 M, Thon V, S\u00e1rfyov\u00e1 M, Bl\u00e1ha L, Svobodn\u00edk A, Lokaj J, et al. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Clin Exp Immunol. 2006;143:373\u20139.","journal-title":"Clin Exp Immunol"},{"key":"99_CR8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2249.2000.01317.x","volume":"121","author":"RM Aspalter","year":"2000","unstructured":"Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol. 2000;121:506\u201314.","journal-title":"Clin Exp Immunol"},{"key":"99_CR9","doi-asserted-by":"crossref","unstructured":"Nechvatalova J, Pikulova Z, Stikarovska D, Pesak S, Vlkova M, Litzman J. B-lymphocyte subpopulations in patients with selective IgA deficiency. J Clin Immunol. 2012;32:441\u20138.","DOI":"10.1007\/s10875-012-9655-6"},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2249.2006.03274.x","volume":"147","author":"J Litzman","year":"2007","unstructured":"Litzman J, Vlkov\u00e1 M, Pikulov\u00e1 Z, Stikarovsk\u00e1 D, Lokaj J. T and B lymphocyte subpopulations and activation\/differentiation markers in patients with selective IgA deficiency. Clin Exp Immunol. 2007;147:249\u201354.","journal-title":"Clin Exp Immunol"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2249.2012.04620.x","volume":"169","author":"RR Barbosa","year":"2012","unstructured":"Barbosa RR, Silva SP, Silva SL, Tendeiro R, Melo AC, Pedro E, et al. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin Exp Immunol. 2012;169:263\u201372.","journal-title":"Clin Exp Immunol"},{"key":"99_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrmicro2848","volume":"10","author":"NG Sandler","year":"2012","unstructured":"Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655\u201366.","journal-title":"Nat Rev Microbiol"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ibd.21040","volume":"16","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis. 2010;16:703\u201311.","journal-title":"Inflamm Bowel Dis"},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-american group for immunodeficiency) and ESID (european society for immunodeficiencies). Clin Immunol. 1999;93:190\u20137.","journal-title":"Clin Immunol"},{"key":"99_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77\u201385.","journal-title":"Blood"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes M, G\u00e9rard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49:1329\u201338.","journal-title":"Clin Infect Dis"},{"key":"99_CR17","doi-asserted-by":"crossref","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol. 1990;1:43\u20136.","DOI":"10.1097\/00001648-199001000-00010"},{"key":"99_CR18","doi-asserted-by":"crossref","unstructured":"Perneger TV. What\u2019s wrong with Bonferroni adjustments. BMJ. 1998;316:1236\u20138.","DOI":"10.1136\/bmj.316.7139.1236"},{"key":"99_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00063030-200519010-00007","volume":"19","author":"C Ibanez","year":"2005","unstructured":"Ibanez C, Sune P, Fierro A, Rodriguez S, Lopez M, Alvarez A, et al. Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia. Biodrugs. 2005;19:59\u201365.","journal-title":"Biodrugs"},{"key":"99_CR20","first-page":"449","volume":"18","author":"N Rezaei","year":"2008","unstructured":"Rezaei N, Aghamohammadi A, Kardar GA, Nourizadeh M, Pourpak Z. T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2008;18:449\u201353.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03256928","volume":"31","author":"K Kasztalska","year":"2011","unstructured":"Kasztalska K, Ciebiada M, Cebula-Obrzut B, G\u00f3rski P. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study. Clin Drug Investig. 2011;31:299\u2013307.","journal-title":"Clin Drug Investig"},{"key":"99_CR22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","volume":"55","author":"K Li","year":"2012","unstructured":"Li K, Li NL, Wei D, Pfeffer SR, Fan M, Pfeffer LM. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatol. 2012;55:666\u201375.","journal-title":"Hepatol"},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI119488","volume":"99","author":"C Gabay","year":"1997","unstructured":"Gabay C, Smith MF, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest. 1997;99:2930\u201340.","journal-title":"J Clin Invest"},{"key":"99_CR24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V93.4.1299","volume":"93","author":"C Gabay","year":"1999","unstructured":"Gabay C, Porter B, Guenette D, Billir B, Arend WP. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood. 1999;93:1299\u2013307.","journal-title":"Blood"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","volume":"27","author":"C Auffray","year":"2009","unstructured":"Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669\u201392.","journal-title":"Annu Rev Immunol"},{"key":"99_CR26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/QAI.0b013e3181c1d4fe","volume":"52","author":"J Han","year":"2009","unstructured":"Han J, Wang B, Han N, Zhao Y, Song C, Feng X, et al. CD14 (high) CD16 (+) rather than CD14 (low) CD16 (+) monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr. 2009;52:553\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"99_CR27","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008;3:e2516.","journal-title":"PLoS One"},{"key":"99_CR28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2249.2007.03512.x","volume":"150","author":"AL Amoras","year":"2007","unstructured":"Amoras AL, da Silva MT, Zollner RL, Kanegane H, Miyawaki T, Vilela MM. Expression of Fc gamma and complement receptors in monocytes of X-linked agammaglobulinaemia and common variable immunodeficiency patients. Clin Exp Immunol. 2007;150:422\u20138.","journal-title":"Clin Exp Immunol"},{"key":"99_CR29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/clin.1994.1032","volume":"70","author":"P Aukrust","year":"1994","unstructured":"Aukrust P, M\u00fcller F, Fr\u00f8land SS. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol. 1994;70:217\u201324.","journal-title":"Clin Immunol Immunopathol"},{"key":"99_CR30","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2004-06-2423","volume":"105","author":"AM Holm","year":"2005","unstructured":"Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS. Abnormal interleukin-7 function in common variable immunodeficiency. Blood. 2005;105:2887\u201390.","journal-title":"Blood"},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2249.2009.04013.x","volume":"158","author":"B Fevang","year":"2009","unstructured":"Fevang B, Yndestad A, Dam\u00e5s JK, Halvorsen B, Holm AM, Beiske K, et al. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation. Clin Exp Immunol. 2009;158:237\u201345.","journal-title":"Clin Exp Immunol"},{"key":"99_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2249.2006.03063.x","volume":"144","author":"N Martinez-Pomar","year":"2006","unstructured":"Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR, et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol. 2006;144:233\u20138.","journal-title":"Clin Exp Immunol"},{"key":"99_CR34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4049\/jimmunol.164.1.488","volume":"164","author":"R Cambronero","year":"2000","unstructured":"Cambronero R, Sewell WA, North ME, Webster AD, Farrant J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol. 2000;164:488\u201394.","journal-title":"J Immunol"},{"key":"99_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2567.2005.02257.x","volume":"117","author":"O Shimozato","year":"2006","unstructured":"Shimozato O, Ugai S, Chiyo M, Takenobu H, Nagakawa H, Wada A, et al. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunol. 2006;117:22\u20138.","journal-title":"Immunol"},{"key":"99_CR36","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.4049\/jimmunol.165.6.3162","volume":"165","author":"DA Schmitt","year":"2000","unstructured":"Schmitt DA, Ullrich SE. Exposure to ultraviolet radiation causes dendritic cells\/macrophages to secrete immune-suppressive IL-12p40 homodimers. J Immunol. 2000;165:3162\u20137.","journal-title":"J Immunol"},{"key":"99_CR37","doi-asserted-by":"crossref","first-page":"e22848","DOI":"10.1371\/journal.pone.0022848","volume":"6","author":"RR Barbosa","year":"2011","unstructured":"Barbosa RR, Silva SP, Silva SL, Melo AC, Pedro E, Barbosa MP, et al. Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS One. 2011;6:e22848.","journal-title":"PLoS One"},{"key":"99_CR38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/135965350801300815","volume":"13","author":"T Reiberger","year":"2008","unstructured":"Reiberger T, Aberle JH, Kundi M, Kohrgruber N, Rieger A, Gangl A, et al. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. Antivir Ther. 2008;13:969\u201376.","journal-title":"Antivir Ther"},{"key":"99_CR39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","volume":"194","author":"AI Romero","year":"2006","unstructured":"Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, Pawlotsky JM, et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis. 2006;194:895\u2013903.","journal-title":"J Infect Dis"},{"key":"99_CR40","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.1003844","volume":"186","author":"A Waddell","year":"2011","unstructured":"Waddell A, Ahrens R, Steinbrecher K, Donovan B, Rothenberg ME, Munitz A, et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C (high) CCR2 (+) inflammatory monocyte\/macrophage-derived CCL11. J Immunol. 2011;186:5993\u20136003.","journal-title":"J Immunol"},{"key":"99_CR41","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.4049\/jimmunol.163.7.3976","volume":"163","author":"S Ying","year":"1999","unstructured":"Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol. 1999;163:3976\u201384.","journal-title":"J Immunol"},{"key":"99_CR42","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1084\/jem.178.5.1629","volume":"178","author":"H Tilg","year":"1993","unstructured":"Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993;178:1629\u201336.","journal-title":"J Exp Med"},{"key":"99_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/cimm.1998.1255","volume":"184","author":"PP McDonald","year":"1998","unstructured":"McDonald PP, Gasperini S, Calzetti F, Cassatella MA. Modulation by interferon-gamma of the production and gene expression of IL-1 receptor antagonist in human neutrophils. Cell Immunol. 1998;184:45\u201350.","journal-title":"Cell Immunol"},{"key":"99_CR44","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/107999099312957","volume":"19","author":"U Bank","year":"1999","unstructured":"Bank U, Reinhold D, Schneemilch C, Kunz D, Synowitz HJ, Ansorge S. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res. 1999;19:1277\u201387.","journal-title":"J Interferon Cytokine Res"},{"key":"99_CR45","first-page":"237","volume":"61","author":"BC Sheu","year":"2001","unstructured":"Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001;61:237\u201342.","journal-title":"Cancer Res"},{"key":"99_CR46","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","volume":"118","author":"ZZ Yang","year":"2011","unstructured":"Yang ZZ, Grote DM, Ziesmer SC, Manske MK, Witzig TE, Novak AJ, et al. Soluble IL-2R\u03b1 facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma. Blood. 2011;118:2809\u201320.","journal-title":"Blood"},{"key":"99_CR47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-3083.2010.02427.x","volume":"72","author":"R Cabrera","year":"2010","unstructured":"Cabrera R, Ararat M, Eksioglu EA, Cao M, Xu Y, Wasserfall C, et al. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma. Scand J Immunol. 2010;72:293\u2013301.","journal-title":"Scand J Immunol"},{"key":"99_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","volume":"13","author":"E Bien","year":"2008","unstructured":"Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 2008;13:1\u201326.","journal-title":"Biomarkers"},{"key":"99_CR49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00125-013-3113-8","volume":"57","author":"K Downes","year":"2014","unstructured":"Downes K, Marcovecchio ML, Clarke P, Cooper JD, Ferreira RC, Howson JM, et al. Plasma concentrations of soluble IL-2 receptor \u03b1 (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients. Diabetologia. 2014;57:366\u201372.","journal-title":"Diabetologia"},{"key":"99_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.1991.tb05805.x","volume":"86","author":"ME North","year":"1991","unstructured":"North ME, Spickett GP, Webster AD, Farrant J. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. Clin Exp Immunol. 1991;86:252\u20135.","journal-title":"Clin Exp Immunol"},{"key":"99_CR51","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2011.09.047","volume":"129","author":"R Micol","year":"2012","unstructured":"Micol R, Kayal S, Mahlaoui N, Beaut\u00e9 J, Brosselin P, Dudoit Y, et al. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129:770\u20137.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0099-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0099-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T14:00:14Z","timestamp":1689516014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0099-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0099-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]}}}